Merck & Co Inc (MRK)
121.44
-0.08
(-0.07%)
USD |
NYSE |
Mar 18, 16:00
122.00
+0.56
(+0.46%)
Pre-Market: 07:28
Merck Total Assets (Quarterly): 106.68B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 106.68B |
September 30, 2023 | 106.73B |
June 30, 2023 | 104.47B |
March 31, 2023 | 107.80B |
December 31, 2022 | 109.16B |
September 30, 2022 | 107.08B |
June 30, 2022 | 107.10B |
March 31, 2022 | 106.67B |
December 31, 2021 | 105.69B |
September 30, 2021 | 93.49B |
June 30, 2021 | 90.69B |
March 31, 2021 | 90.85B |
December 31, 2020 | 91.59B |
September 30, 2020 | 89.80B |
June 30, 2020 | 90.62B |
March 31, 2020 | 84.91B |
December 31, 2019 | 84.40B |
September 30, 2019 | 83.33B |
June 30, 2019 | 83.96B |
March 31, 2019 | 82.35B |
December 31, 2018 | 82.64B |
September 30, 2018 | 85.13B |
June 30, 2018 | 85.04B |
March 31, 2018 | 86.04B |
December 31, 2017 | 87.87B |
Date | Value |
---|---|
September 30, 2017 | 91.68B |
June 30, 2017 | 92.80B |
March 31, 2017 | 96.56B |
December 31, 2016 | 95.38B |
September 30, 2016 | 98.34B |
June 30, 2016 | 96.48B |
March 31, 2016 | 98.76B |
December 31, 2015 | 101.68B |
September 30, 2015 | 101.23B |
June 30, 2015 | 102.58B |
March 31, 2015 | 108.34B |
December 31, 2014 | 98.17B |
September 30, 2014 | 101.81B |
June 30, 2014 | 97.86B |
March 31, 2014 | 108.46B |
December 31, 2013 | 105.64B |
September 30, 2013 | 106.42B |
June 30, 2013 | 106.88B |
March 31, 2013 | 106.20B |
December 31, 2012 | 106.13B |
September 30, 2012 | 106.30B |
June 30, 2012 | 105.52B |
March 31, 2012 | 105.51B |
December 31, 2011 | 105.13B |
September 30, 2011 | 106.53B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
82.35B
Minimum
Mar 2019
109.16B
Maximum
Dec 2022
96.37B
Average
92.54B
Median
Total Assets (Quarterly) Benchmarks
Amgen Inc | 97.15B |
Gilead Sciences Inc | 62.12B |
Johnson & Johnson | 167.56B |
Harpoon Therapeutics Inc (DELISTED) | 47.58M |
Moderna Inc | 18.43B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 69.04B |
Shareholders Equity (Quarterly) | 37.58B |
Debt to Equity Ratio | 0.9328 |
Current Ratio | 1.252 |
Net Debt Paydown Yield | -0.34% |